Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IRAK1, a potential therapeutic target for rheumatoid arthritis?

× No keyword cloud information.

9 in total

1. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.

Authors: Kazuhiro Yokota; Takashi Miyazaki; Hossein Hemmatazad; Renate E Gay; Christoph Kolling; Ursula Fearon; Hiromichi Suzuki; Toshihide Mimura; Steffen Gay; Caroline Ospelt
Journal: Arthritis Rheum Date: 2012-05

2. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility.

Authors: Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Ioannis Georgiou; Alexandros A Drosos
Journal: Joint Bone Spine Date: 2010-09-25 Impact factor: 4.929

3. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation.

Authors: T Iguchi; M Ziff
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

4. Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis.

Authors: Y M Mosaad; A Abdelsalam; S R El-Bassiony
Journal: Int J Immunogenet Date: 2011-08-02 Impact factor: 1.466

5. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts.

Authors: Mi-La Cho; Ji-Hyeon Ju; Hae-Rim Kim; Hye-Joa Oh; Chang-Min Kang; Joo-Yeon Jhun; Seon-Yeong Lee; Mi-Kyung Park; Jun-Ki Min; Sung-Hwan Park; Sang-Heon Lee; Ho-Youn Kim
Journal: Immunol Lett Date: 2006-12-11 Impact factor: 3.685

6. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.

Authors: Eugene Y Chiang; Xin Yu; Jane L Grogan
Journal: J Immunol Date: 2010-12-15 Impact factor: 5.422

IRAK1, a potential therapeutic target for rheumatoid arthritis?

1. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.

2. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility.

3. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation.

4. Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis.

5. Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts.

6. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.

Review 7. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.

8. IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis.

9. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients.